Skip to main content

Advertisement

SpringerLink
Log in

Eyelid and eyelash changes due to prostaglandin analog therapy in unilateral treatment cases

  • Clinical Investigation
  • Published:
Japanese Journal of Ophthalmology Aims and scope Submit manuscript

Abstract

Purpose

To investigate the incidence of adverse effects on eyelids and eyelashes related to treatment with prostaglandin analogs (PGAs) in patients who apply the medication in only one eye.

Methods

A clinical examination of 39 glaucoma patients treated for over 3 months continuously in one eye with one of four PGAs. Face photographs were used to judge adverse effects of PGA treatment on eyelids and eyelashes of the treated eyes by comparing them with the eyelids and eyelashes of the contralateral eyes. Each of three examiners then calculated scores for the eyelids and eyelashes by counting how many adverse effects were present (out of five possible effects for eyelids and two for eyelashes). The findings for the eyelids or eyelashes were considered “positive” if two or more examiners judged that at least one adverse effect was present.

Results

Thirty-five (89.7 %) patients were judged to have positive eyelid findings and 37 (94.9 %) patients were judged to have positive eyelash findings. There was a significant correlation between the period of PGA administration and eyelid score (P = 0.0218).

Conclusion

There was a high incidence of adverse effects caused by PGAs in the eyelids and eyelashes. The frequency of adverse effects of the eyelid seemed to increase as the use of PGAs was prolonged. The cosmetic complications caused by PGA use should be considered, and patients should be informed of them in advance.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Maruyama K. Medical therapy for normal-tension glaucoma. Atarashii Ganka (in Japanese). 2008;25:795–8.

    Google Scholar 

  2. Kashiwagi K, Tsumura T, Tsukahara S. Long-term effects of latanoprost monotherapy on intraocular pressure in Japanese glaucoma patients. J Glaucoma. 2008;17:662–6.

    Article  PubMed  Google Scholar 

  3. Yamazaki S, Nanno M, Kimura T, Suzumura H, Yoshikawa K. Effects of switching to SofZia-preserved travoprost in patients who preserved with superficial punctate keratopathy while under treatment with latanoprost. Jpn J Ophthalmol. 2010;54:7–14.

    Article  PubMed  Google Scholar 

  4. Peplinski LS, Smith KA. Deepening of lid sulcus from topical bimatoprost therapy. Optom Vis Sci. 2004;81:574–7.

    Article  PubMed  Google Scholar 

  5. Filippopoulos T, Paula JS, Torun N, Hatton MP, Pasquale LR, Grosskreutz CL. Periorbital changes associated with topical bimatoprost. Ophthal Plast Reconstr Surg. 2008;24:302–7.

    Article  PubMed  Google Scholar 

  6. Ha SJ, Kim HD, Lee HJ, Choi K-S. Deep lid sulcus and blepharoptosis after treatment with topical travoprost and bimatoprost. Am Acad Ophthalmol. 2008;11:8–11.

    Google Scholar 

  7. Tappeiner C, Perren B, Iliev ME, Frueh BE, Goldblum D. Orbital fat atrophy in glaucoma patients treated with topical bimatoprost: can bimatoprost cause enophthalmos? Klin Monbl Augenheilkd. 2008;225:443–5.

    Article  PubMed  CAS  Google Scholar 

  8. Yam JC, Yuen NS, Chan CW. Bilateral deepening of upper lid sulcus from topical bimatoprost therapy. J Ocul Pharmacol Ther. 2009;25:471–2.

    Article  PubMed  CAS  Google Scholar 

  9. Yang HK, Park KH, Kim TW, Kim DM. Deepening of eyelid superior sulcus during topical travoprost treatment. Jpn J Ophthalmol. 2009;53:176–9.

    Article  PubMed  CAS  Google Scholar 

  10. Jayaprakasam A, Ghazi-Nouri S. Periorbital fat atrophy; an unfamiliar side effect of prostaglandin analogues. Orbit. 2010;29:357–9.

    Article  PubMed  Google Scholar 

  11. Park J, Cho HK, Moon JI. Changes to upper eyelid orbital fat from use of topical bimatoprost, travoprost, and latanoprost. Jpn J Ophthalmol. 2011;55:22–7.

    Article  PubMed  CAS  Google Scholar 

  12. Watanabe I, Maruo H, Watanabe I. Deepening of the sulcus of upper eyelid following instillation of travoprost. Rinsho Ganka (in Japanese). 2011;65:679–82.

    Google Scholar 

  13. Aihara M, Shirato S, Sakata R. Incidence of deepening of the upper eyelid sulcus after switching from latanoprost to bimatoprost. Jpn J Ophthalmol. 2011;55:600–4.

    Article  PubMed  Google Scholar 

  14. Chiba T, Kashiwagi K, Kogure S, Abe K, Shibuya T, Furuichi M, et al. Iridial pigmentation induced by latanoprost ophthalmic solution in Japanese glaucoma patients. J Glaucoma. 2001;10:406–10.

    Article  PubMed  CAS  Google Scholar 

  15. Inoue K, Wakakura M, Inoue J, Matsuo H, Hara T, Tomita G. Adverse reaction after use of latanoprost in Japanese glaucoma patients. Nippon Ganka Gakkai Zasshi (in Japanese). 2006;110:581–7.

    Google Scholar 

  16. Alm A, Schoenfelder J, McDermott J. A 5-year, multicenter, open-label, safety study of adjunctive latanoprost therapy for glaucoma. Arch Ophthalmol. 2004;122:957–65.

    Article  PubMed  CAS  Google Scholar 

  17. Goldberg I, Li XY, Selaru P, Paggiarino D. A 5-year, randomized, open-label safety study of latanoprost and usual care in patients with open-angle glaucoma or ocular hypertension. Eur J Ophthalmol. 2008;18:408–16.

    PubMed  CAS  Google Scholar 

  18. Hara T. Increased iris pigmentation after use of latanoprost in Japanese brown eyes. Nippon Ganka Gakkai Zasshi (in Japanese). 2001;105:314–21.

    CAS  Google Scholar 

  19. Latanoprost-Induced Iris Pigmentation Study Group. Incidence of a latanoprost-induced increase in iris pigmentation in Japanese eyes. Jpn J Ophthalmol. 2006;50:96–9.

    Article  Google Scholar 

  20. Lee AJ, McCluskey P. Clinical utility and differential effects of prostaglandin analogs in the management of raised intraocular pressure and ocular hypertension. Clin Ophthalmol. 2010;4:741–64.

    PubMed  Google Scholar 

  21. Kitazawa Y, Komemushi S. Single-masked, randomized, parallel-group comparison of bimatoprost ophthalmic solution and latanoprost ophthalmic solution in patients with primary open-angle glaucoma or ocular hypertension. Atarashii Ganka (in Japanese). 2010;27:401–10.

    Google Scholar 

  22. Doshi M, Edward DP, Osmanovic S. Clinical course of bimatoprost-induced periocular skin changes in Caucasians. Ophthalmology. 2006;113:1961–7.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Ophthalmology and Visual Science, Graduated School of Medical and Dental Sciences, Niigata University, 1-757 Asahimachi-dori, Niigata, Niigata, 951-8510, Japan

    Takaiko Yoshino, Takeo Fukuchi, Tetsuya Togano, Masaaki Seki, Hiroko Ikegaki & Haruki Abe

Authors
  1. Takaiko Yoshino
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Takeo Fukuchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tetsuya Togano
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Masaaki Seki
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hiroko Ikegaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Haruki Abe
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Takaiko Yoshino.

About this article

Cite this article

Yoshino, T., Fukuchi, T., Togano, T. et al. Eyelid and eyelash changes due to prostaglandin analog therapy in unilateral treatment cases. Jpn J Ophthalmol 57, 172–178 (2013). https://doi.org/10.1007/s10384-012-0199-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10384-012-0199-3

Keywords

Search

Navigation